MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Deep Brain Stimulation Increases Motivation to Obtain Larger Rewards in Parkinson’s Disease

    S. Brener, E. Pegolo, A. Hahn, J. Suh, M. Scherbakova, K. Balagula, P. Lockwood, M. Apps, S. Little (Birmingham, United Kingdom)

    Objective: To assess the effects of deep brain stimulation (DBS) on effort and reward processing for self-benefitting and prosocial behavior in people with Parkinson’s Disease…
  • 2025 International Congress

    A case of Parkinson’s Disease whose Daily Levodopa/Carbidopa Intestinal Gel dose has been determined by her spouse and prevented Long-term Fluctuations

    Y. Okuma (Izunokuni, Japan)

    Objective: To present a case of Parkinson’s disease (PD) whose daily levodopa/carbidopa intestinal gel (LCIG) dose has been determined by her spouse and prevented long-term…
  • 2025 International Congress

    Variations of Self-Perceived Cognitive Changes by Ethnicity in Parkinson’s Disease Patients

    H. Lee, P. Parekh, A. Arroyo, I. Balbo, A. Fanning, R. Alcalay, J. Agin-Liebes (New York, USA)

    Objective: To study perceptions of cognitive function across ethnic groups by comparing a subjective rating with an objective assessment for patients with PD (PWP). Background:…
  • 2025 International Congress

    What women want: real-life experiences of women with Parkinson’s disease

    O. Horbach, D. Dirks, A. Sukar, E. Slow, M. Picillo, V. Bruno (Calgary, Canada)

    Objective: To explore the experiences of women with Parkinson’s disease (WwPD) in healthcare access, physical and mental health, relationships, and future planning, identifying unmet needs.…
  • 2025 International Congress

    Long-Term Dementia Risk in the General Parkinson Disease Population

    J. Maple-Grødem, ø. Rustan, D. Bäckström, M. Camacho, C. Counsell, I. Dalen, L. Forsgren, R. Lawson, A. Macleod, C. Williams-Gray, A. Yarnall, OB. Tysnes, G. Alves (Stavanger, Norway)

    Objective: To estimate the long-term risk of developing dementia in the general Parkinson’s disease (PD) population and to assess the influence of age at PD…
  • 2025 International Congress

    The East London Parkinson Disease Project: cultural fairness of common cognitive screening tests

    A. Zirra, KC. Dey, E. Camboe, E. Bhadra, T. Haque, S. Waters, DA. Gallagher, C. Budu, B. Huxford, C. Simonet, C. Edwards, S. Ali, R. Weil, N. Mukadam, AJ. Lees, T. Boyle, MT. Perinan, CR. Marshall, AJ. Noyce (London, United Kingdom)

    Objective: The first objective of this work was to report the prevalence of Parkinson’s disease (PD) cognitive impairment in three ethnicities from the East London…
  • 2025 International Congress

    Duration of Illness and Response to Pimavanserin in Parkinson’s Disease Psychosis: Post-Hoc Analysis of Clinical Trial Data

    K. Dashtipour, A. Espay, M. Tagliati, G. Brunson, X. Feng, N. Rashid, L. Chrones (Loma Linda, USA)

    Objective: To examine individual responses to pimavanserin in patients with Parkinson’s disease psychosis (PDP) initiating treatment <6 vs ≥6 months and <12 vs ≥12 months…
  • 2025 International Congress

    Approach into the genetics of cognitive performance in Mexican Parkinson’s Disease patients.

    A. Lázaro Figueroa, P. Reyes-Pérez, A. Morales, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, N. Gandarilla-Martínez, K. Salinas-Barboza, D. Oropeza, J. Esquivias, I. Hernández-Ruiz, G. de Anda, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (CDMX, Mexico)

    Objective: To compare the allele frequencies of genetic variants associated with cognitive impairment between Parkinson's Disease (PD) patients and controls and to examine their interaction…
  • 2025 International Congress

    Unravelling The Relationship Between Autonomic Nervous System And Anxiety In People With Parkinson’s Disease

    L. Ricciardi, A. Fanciulli, F. Cucinotta, B. Ishahara, I. Cociasu, F. Baig, E. Pereira, M. Hart, F. Morgante, E. Makovac (London, United Kingdom)

    Objective: To investigate objective cardiovascular measures in relation to anxiety in PD patients, and the structural neural changes underlying this putative interaction.T Background: Anxiety and…
  • 2025 International Congress

    Metabolic dysfunction-associated steatotic liver disease, body mass index, and risk of Parkinson’s disease

    SJ. Chung, TS. Lim, J. Jeon, JK. Kim, J. Kim, PH. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to investigate how metabolic dysfunction-associated steatotic liver disease (MASLD) and body mass index (BMI) together influence the incidence of Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley